Skip to main content
. 2019 Oct 26;11(10):891–903. doi: 10.4252/wjsc.v11.i10.891

Table 1.

Intervention and study population overview

Study Population
Intervention
Ref. Country Sample size Age (yr) Patient condition Intervention and study groups Application route Type of stem cells Source Origin Dose
Chen et al[45], 2013 China 60 1-35 CP, GMFCS level 3 to 5 Group 1: SC + rehabilitation Group 2: Rehabilitation only Intrathecal Mesenchymal stem cells in vitro transformed to neural stem cell- like cells Bone marrow Autologous Fixed quantity of 1-2 × 107 cells, twice
Huang et al[46], 2018 China 56 3-12 CP Group 1: SC + rehabilitation Group 2: Placebo + rehabilitation Intravenous Mesenchymal stem cells Cord blood Allogeneic Fixed quantity of 5 × 107 cells, 4 times
Kang et al[47], 2015 South Korea 36 0.5-20 CP, GMFCS level 1 to 5 Group 1: SC Group 2: Placebo No rehabilitation Intravenous/intraarterial Mononuclear cells Cord blood Allogeneic1 5.46 × 107 cells/kg, once
Liu et al[40], 2017 China 105 0.5-12.5 Spastic CP, GMFCS level 2 to 5 Group 1: MNC Group 2: MSC Group 3: rehabilitation Intrathecal Mesenchymal stromal cells and mononuclear cells Bone marrow Autologous 106 cells/kg, 4 times
Luan et al[44], 2012 China 91 < 0.5-3.5 CP, GMFSC level 1 to 5 Group 1: SC + rehabilitation Group 2: rehabilitation only Intraventricular Neural progenitor cells Aborted healthy fetuses’ forebrains Allogeneic Fixed quantity of 8-10 × 106 cells, once
Min et al[39], 2013 South Korea 105 0.8-10 CP Group 1: SC+ EPO + rehabilitation Group 2: placebo SC + EPO + rehabilitation Group 3: placebo SC+ placebo + rehabilitation Intravenous Mononuclear cells Cord blood Allogeneic1 ≥ 3 × 107 cells/kg, once
Rah et al[42], 2017 South Korea 57 2-10 Non-severe CP Group 1: G-CSF at baseline, SC 1 mo later Group 2: G-CSF at baseline, placebo 1 mo later crossover at 7 mo Intravenous Mobilized mononuclear cells Peripheral blood Autologous 5.97 × 108 cells/ kg, once
Sun et al[41], 2017 USA 63 1-6 CP of any type, GMFCS Level 2 to 4 or 1 with hemiplegia Group 1: SC + rehabilitation Group 2: Placebo + rehabilitation Intravenous Mononuclear cells Cord blood Autologous 2 × 107 cells/kg, once
1

Administation of cyclosporine. MNC: Mononuclear cells; MSC: Mesenchymal stem cells; EPO: Erythropoietin; CP: Cerebral palsy; SC: Stem cells; GMFCS: Gross motor function classification system.